Paratek Pharmaceuticals, Inc.
Simbol: PRTK
NASDAQ
2.23
USDTržna cena danes
-3.0521
Razmerje P/E
0.1791
Razmerje PEG
127.83M
Kapaciteta MRK
- 0.00%
Donos DIV
Paratek Pharmaceuticals, Inc. (PRTK) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 178.97 | 34.2 | 95.5 | 125.2 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 29.92 | 0 | 15.1 | 20 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 190.45 | 78 | 33.1 | 15.7 | |||||||||||||||||||||
balance-sheet.row.inventory | 62.72 | 16.6 | 11 | 14.6 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 41.91 | 7.9 | 12.4 | 7.8 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 474.42 | 136.8 | 152.1 | 164.1 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 8.63 | 2.4 | 2.6 | 3 | |||||||||||||||||||||
balance-sheet.row.goodwill | 3.32 | 0.8 | 0.8 | 0.8 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 3.32 | 0.8 | 0.8 | 0.8 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 140.11 | 32.5 | 28.4 | 8.9 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 152.06 | 35.7 | 31.8 | 12.7 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 626.48 | 172.5 | 183.9 | 176.9 | |||||||||||||||||||||
balance-sheet.row.account-payables | 21.68 | 5.3 | 5.4 | 1.8 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 164.04 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 872.3 | 258.4 | 255.7 | 252 | |||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 91.2 | 32.1 | 25.9 | 22.1 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1042.35 | 306.2 | 280.4 | 255.2 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 4.89 | 1.5 | 1.3 | 1.5 | |||||||||||||||||||||
balance-sheet.row.total-liab | 1354.08 | 343.6 | 311.7 | 279.1 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.common-stock | 0.23 | 0.1 | 0.1 | 705.5 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | -3769.48 | -930.4 | -866.9 | -807.8 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -0.12 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3041.77 | 759.4 | 739.1 | 0 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | -727.6 | -171 | -127.8 | -102.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 626.48 | 172.5 | 183.9 | 176.8 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-equity | -727.6 | -171 | -127.8 | -102.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 626.48 | - | - | - | |||||||||||||||||||||
Total Investments | 29.92 | 0 | 15.1 | 20 | |||||||||||||||||||||
balance-sheet.row.total-debt | 1036.34 | 258.4 | 255.7 | 252 | |||||||||||||||||||||
balance-sheet.row.net-debt | 887.3 | 224.2 | 175.4 | 146.9 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -62.73 | -63.6 | -59.1 | -96.5 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0.31 | 0.5 | 0.4 | 0.6 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 1.1 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 10.34 | 12.3 | 14.3 | 10.2 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 23.96 | -20.8 | -8.2 | -20.3 | |||||||||||||||||||
cash-flows.row.account-receivables | -5.71 | -40.4 | -21.8 | -7.5 | |||||||||||||||||||
cash-flows.row.inventory | -2.05 | -9.1 | -15.5 | -11.8 | |||||||||||||||||||
cash-flows.row.account-payables | 8.96 | 7.7 | 6.8 | 1.6 | |||||||||||||||||||
cash-flows.row.other-working-capital | 22.76 | 21 | 22.3 | -2.6 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 4.91 | 5.4 | 4.3 | 1.5 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -23.22 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.07 | 0 | -0.4 | -0.4 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | -15.16 | -15.2 | -15.1 | -29.6 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 30 | 30 | 20 | 122.5 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 15.2 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 29.97 | 14.8 | 4.5 | 92.5 | |||||||||||||||||||
cash-flows.row.debt-repayment | -3.73 | -2.9 | -0.3 | -70 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 7.3 | 18.4 | 21.9 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.other-financing-activites | -0.12 | 0.7 | 0.3 | 59.4 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -3.57 | 5.1 | 18.3 | 11.3 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 3.18 | -46.2 | -25.4 | 0.4 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 149.55 | 34.4 | 80.6 | 106 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 146.37 | 80.6 | 106 | 105.6 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | -23.22 | -66.1 | -48.3 | -103.4 | |||||||||||||||||||
cash-flows.row.capital-expenditure | -0.07 | 0 | -0.4 | -0.4 | |||||||||||||||||||
cash-flows.row.free-cash-flow | -23.29 | -66.2 | -48.6 | -103.8 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 167.74 | 150.8 | 121 | 43.5 | ||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 25.3 | 23.1 | 21.5 | 8.7 | ||||||||||||||||||||||
income-statement-row.row.gross-profit | 142.45 | 127.7 | 99.4 | 34.9 | ||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
income-statement-row.row.research-development | 38.83 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.other-expenses | -7.38 | -9.5 | -9.2 | -3.4 | ||||||||||||||||||||||
income-statement-row.row.operating-expenses | 186.99 | 173.9 | 140.5 | 110.4 | ||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 212.29 | 197 | 162.1 | 119 | ||||||||||||||||||||||
income-statement-row.row.interest-income | 0.99 | 0.8 | 0.1 | 1.5 | ||||||||||||||||||||||
income-statement-row.row.interest-expense | 18.86 | 18.1 | 17.4 | 20.2 | ||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -12.98 | -17.3 | -17.4 | -21 | ||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -7.38 | -9.5 | -9.2 | -3.4 | ||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -12.98 | -17.3 | -17.4 | -21 | ||||||||||||||||||||||
income-statement-row.row.interest-expense | 18.86 | 18.1 | 17.4 | 20.2 | ||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0.95 | 1.3 | 0.4 | 1.6 | ||||||||||||||||||||||
income-statement-row.row.ebitda-caps | -43.4 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.operating-income | -44.54 | -46.2 | -41.1 | -75.5 | ||||||||||||||||||||||
income-statement-row.row.income-before-tax | -62.56 | -63.5 | -58.5 | -96.5 | ||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 4.56 | 0.1 | 0.6 | 19.7 | ||||||||||||||||||||||
income-statement-row.row.net-income | -67.12 | -63.6 | -59.1 | -116.3 |
Pogosto zastavljeno vprašanje
Kaj je Paratek Pharmaceuticals, Inc. (PRTK) skupna sredstva?
Paratek Pharmaceuticals, Inc. (PRTK) skupna sredstva so 172538000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so 67270000.000.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.850.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je -0.190.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je -0.299.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so -0.201.
Kaj je Paratek Pharmaceuticals, Inc. (PRTK) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je -63566000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 258414000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 173941000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 42685000.000.